Wanbury’s subsidiary files petition for voluntary insolvency

08 Nov 2013 Evaluate

Wanbury’s subsidiary - Cantabria Pharma S.L., Spain, has filed petition for voluntary insolvency in the Commercial Courts of Madrid, Spain on November 04, 2013.

Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has a presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006.

Wanbury Share Price

232.80 -1.35 (-0.58%)
29-Dec-2025 15:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.50
Dr. Reddys Lab 1268.40
Cipla 1496.00
Zydus Lifesciences 906.00
Lupin 2081.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×